Auxogyn - Learn More

Auxogyn, Inc. is advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The company’s first product, the non-invasive Early Embryo Viability Assessment System (Eeva), provides quantitative information regarding embryo development, to assist IVF clinics in potentially selecting the best embryo(s) for transfer and optimizing the treatment path for their patients undergoing in vitro fertilization (IVF) procedures.